Daiwa Securities Group Inc. - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 154 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
300.0%0.00%
Q2 2023$10.0%300.0%0.00%
Q1 2023$10.0%300.0%0.00%
Q4 2022$1
-99.9%
300.0%0.00%
Q3 2022$1,0000.0%300.0%0.00%
Q2 2022$1,0000.0%300.0%0.00%
Q1 2022$1,000
-50.0%
300.0%0.00%
Q4 2021$2,0000.0%300.0%0.00%
Q3 2021$2,000
+100.0%
300.0%0.00%
Q2 2021$1,0000.0%300.0%0.00%
Q1 2021$1,0000.0%300.0%0.00%
Q4 2020$1,000
-66.7%
30
-63.4%
0.00%
Q3 2020$3,000
-25.0%
820.0%0.00%
Q2 2020$4,0000.0%820.0%0.00%
Q1 2020$4,000
-20.0%
820.0%0.00%
Q4 2019$5,0000.0%820.0%0.00%
Q3 2019$5,0000.0%820.0%0.00%
Q2 2019$5,000
+25.0%
820.0%0.00%
Q1 2019$4,000
+33.3%
820.0%0.00%
Q4 2018$3,000
-50.0%
820.0%0.00%
Q3 2018$6,0000.0%820.0%0.00%
Q2 2018$6,000
+50.0%
820.0%0.00%
Q1 2018$4,000820.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Hudson Executive Capital LP 1,323,794$79,534,0003.54%
Park West Asset Management LLC 1,171,880$70,406,0002.96%
Matarin Capital Management, LLC 170,008$10,214,0000.98%
Smith, Graham & Co., Investment Advisors, LP 140,014$8,412,0000.82%
Capital Impact Advisors, LLC 33,725$2,026,0000.71%
U S GLOBAL INVESTORS INC 18,800$1,130,0000.51%
CHARTWELL INVESTMENT PARTNERS, LLC 187,989$11,294,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,442,0000.34%
GLOBEFLEX CAPITAL L P 18,751$1,127,0000.21%
Foundry Partners, LLC 70,357$4,227,0000.16%
View complete list of EAGLE PHARMACEUTICALS INC shareholders